CRIS Current Research Information System

SAIA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.979
NA - Nord America 9.454
EU - Europa 6.891
AF - Africa 717
SA - Sud America 628
Continente sconosciuto - Info sul continente non disponibili 555
OC - Oceania 17
Totale 28.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.239
VN - Vietnam 2.993
SG - Singapore 2.569
CN - Cina 2.256
IT - Italia 1.484
GB - Regno Unito 1.176
DE - Germania 1.118
HK - Hong Kong 694
SE - Svezia 644
NL - Olanda 633
BR - Brasile 459
FR - Francia 417
IN - India 372
RU - Federazione Russa 269
KR - Corea 261
UA - Ucraina 259
IE - Irlanda 250
BD - Bangladesh 209
SC - Seychelles 168
JP - Giappone 165
CI - Costa d'Avorio 158
FI - Finlandia 144
ZA - Sudafrica 127
CA - Canada 116
TG - Togo 113
BG - Bulgaria 94
EE - Estonia 85
NG - Nigeria 83
JO - Giordania 78
CH - Svizzera 67
PH - Filippine 67
AR - Argentina 66
TH - Thailandia 52
MX - Messico 46
AT - Austria 44
BE - Belgio 44
PL - Polonia 43
IQ - Iraq 38
IR - Iran 29
TR - Turchia 28
TW - Taiwan 27
PK - Pakistan 26
ES - Italia 24
ID - Indonesia 23
PY - Paraguay 20
SA - Arabia Saudita 20
CL - Cile 19
CO - Colombia 19
EG - Egitto 19
EC - Ecuador 18
LT - Lituania 18
RO - Romania 16
AU - Australia 14
JM - Giamaica 14
UZ - Uzbekistan 13
HR - Croazia 11
GR - Grecia 10
UY - Uruguay 10
DK - Danimarca 9
HN - Honduras 9
MA - Marocco 9
MY - Malesia 9
OM - Oman 8
PE - Perù 8
VE - Venezuela 8
KZ - Kazakistan 7
TN - Tunisia 7
CR - Costa Rica 6
GT - Guatemala 6
KE - Kenya 6
PT - Portogallo 5
SI - Slovenia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IL - Israele 4
LV - Lettonia 4
MK - Macedonia 4
MN - Mongolia 4
NI - Nicaragua 4
NP - Nepal 4
SN - Senegal 4
CZ - Repubblica Ceca 3
ET - Etiopia 3
HU - Ungheria 3
LB - Libano 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
GE - Georgia 2
ML - Mali 2
MM - Myanmar 2
MW - Malawi 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TZ - Tanzania 2
AL - Albania 1
Totale 27.660
Salva come PNG Salva come JPEG
Città #
Singapore 1.734
Ashburn 1.099
Southend 981
Ho Chi Minh City 702
San Jose 661
Hong Kong 647
Fairfield 642
Chandler 624
Hanoi 618
Hefei 494
Santa Clara 480
Frankfurt am Main 408
Eygelshoven 337
Wilmington 304
Seattle 302
Woodbridge 299
Houston 292
Beijing 291
Ann Arbor 268
Princeton 263
Dublin 249
Council Bluffs 226
Seoul 225
Bologna 220
Boardman 219
Cambridge 213
Dong Ket 205
New York 200
Los Angeles 189
Abidjan 157
Lauterbourg 155
Jacksonville 148
Tokyo 131
Milan 125
Turin 117
Lomé 113
Da Nang 106
Westminster 106
Berlin 99
Padova 94
Nanjing 92
Sofia 89
Helsinki 84
São Paulo 84
Buffalo 82
Abeokuta 80
Haiphong 80
Bremen 79
Amman 78
Munich 71
Dallas 69
Rome 65
Bern 56
San Diego 55
Jinan 54
Redondo Beach 53
Changsha 49
Guangzhou 47
Shenyang 47
Shanghai 46
Bengaluru 45
Saint Petersburg 42
Dearborn 41
Turku 41
Brussels 39
Johannesburg 39
Nanchang 37
Chicago 35
Biên Hòa 34
Hebei 34
Tianjin 34
London 33
Florence 32
The Dalles 32
Toronto 31
Hải Dương 30
Phoenix 30
Can Tho 29
Montreal 28
Pune 28
Yubileyny 28
Falkenstein 27
Mülheim 27
Warsaw 27
Atlanta 26
Medford 25
Vienna 25
Quận Bình Thạnh 24
Bangkok 23
Ha Long 23
Nuremberg 23
Paris 23
Mexico City 22
Zhengzhou 22
Jiaxing 21
Olalla 21
Orem 21
San Francisco 21
Shenzhen 21
Taizhou 21
Totale 17.268
Salva come PNG Salva come JPEG
Nome #
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 931
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 286
Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves—Expert Consensus on Procedural Planning and Techniques 273
The role of the vascular surgeon in transcatheter aortic valve implantation 270
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 268
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 268
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 267
[The HEAT-PPCI study] 261
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 259
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction 258
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 252
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 251
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 245
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 241
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 238
La qualità di vita dopo impianto transcatetere di valvola aortica: revisione e valutazione critica della letteratura 236
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 232
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 230
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 230
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 226
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 225
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 223
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 217
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 214
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 210
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 210
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 208
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 207
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 205
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 201
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 200
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 199
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 198
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 198
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 196
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 196
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 196
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 193
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 193
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 190
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 189
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 188
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 188
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 188
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 187
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 187
Transfemoral Transcatheter Aortic Valve Implantation at Hospitals Without On-Site Cardiac Surgery (TAVI at Home): A Multicenter Prospective Interventional Study 186
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 186
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 186
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 184
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 183
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 181
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial 180
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 180
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 179
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 179
Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm 178
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 178
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 176
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 175
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 174
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 173
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 173
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 171
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 170
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 169
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 169
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 169
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 166
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 165
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 164
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 163
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 163
Twelve-Month Outcome of Patients with an Established Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting and Stratified by the Baseline Risk of Bleeding. Insights from the Warfarin and Coronary Stenting (War-Stent) Registry 163
A rescue transcatheter solution for early sutureless basal ring infolding 162
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 162
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 162
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 161
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 161
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 161
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 160
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 159
[Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy] 158
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 157
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 156
Transcatheter Mitral Valve-in-Valve Dislocation: A Rescue Strategy 156
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 155
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 155
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 155
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 155
Recapture of the Sapien-3 Delivery System After Transversal Balloon Rupture Using a Whole Percutaneous Femoral Approach 155
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 153
The safety of drug-eluting stents. 151
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 150
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 150
Correlation between aortic root dimension and coronary ectasia 150
Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery disease 148
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 147
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves 146
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 144
Totale 19.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.157 0 116 132 202 182 119 46 155 80 203 505 417
2022/20233.095 270 438 165 379 251 227 75 183 575 84 271 177
2023/2024919 77 127 41 103 66 258 36 58 23 64 25 41
2024/20254.316 190 533 331 283 642 226 195 121 115 420 252 1.008
2025/202611.610 1.334 1.114 815 846 1.015 820 1.498 440 1.966 820 547 395
2026/2027588 257 331 0 0 0 0 0 0 0 0 0 0
Totale 28.241